Related references
Note: Only part of the references are listed.Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons
Jose Mitjavila et al.
PHARMACOLOGICAL RESEARCH (2018)
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen et al.
MEDICINAL RESEARCH REVIEWS (2017)
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
Lawrence C. Blume et al.
MOLECULAR PHARMACOLOGY (2017)
Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1
Leepakshi Khurana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A. Cairns et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice
A. Busquets-Garcia et al.
MOLECULAR PSYCHIATRY (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster et al.
NEURON (2017)
The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators
Thomas E. Gamage et al.
NEUROPHARMACOLOGY (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Paula Morales et al.
FRONTIERS IN PHARMACOLOGY (2017)
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
Simone Bertini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Srikrishnan Mallipeddi et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes
Dai Lu et al.
CELL STRESS & CHAPERONES (2016)
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
Pushkar M. Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
The Multiple Waves of Cannabinoid 1 Receptor Signaling
Carlos Nogueras-Ortiz et al.
MOLECULAR PHARMACOLOGY (2016)
CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling
Thomas F. Gamage et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators
Thuy Nguyen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
Richard S. Priestley et al.
FASEB JOURNAL (2015)
Distinct Temporal Fingerprint for Cyclic Adenosine Monophosphate (cAMP) Signaling of Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid Receptors
Erin E. Cawston et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska-Jankowska et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model
Alex Straiker et al.
PHARMACOLOGICAL RESEARCH (2015)
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Elham Khajehali et al.
MOLECULAR PHARMACOLOGY (2015)
Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
Tricia H. Smith et al.
MOLECULAR PHARMACOLOGY (2015)
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
Thomas F. Gamage et al.
BEHAVIOURAL PHARMACOLOGY (2014)
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats
Li Jing et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons
Robert B. Laprairie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure-Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)
Nadezhda German et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Optimization of Chemical Functionalities of Indole-2-carboxamides To Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1)
Leepakshi Khurana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallee et al.
SCIENCE (2014)
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats
Yuanyuan Ding et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action
Erin E. Cawston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)
Kwang H. Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structure-Activity Relationship Study of Indole-2-carboxamides Identifies a Potent Allosteric Modulator for the Cannabinoid Receptor 1 (CB1)
Mariam M. Mahmoud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor
Kwang H. Ahn et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Use of Allosteric Targets in the Discovery of Safer Drugs
Ashok Kumar Grover
MEDICAL PRINCIPLES AND PRACTICE (2013)
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie et al.
MOLECULAR PHARMACOLOGY (2013)
Latest advances in novel cannabinoid CB2 ligands for drug abuse and their therapeutic potential
Peng Yang et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and Gi Protein-independent ERK1/2 Kinase Activation
Kwang H. Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors
Mark Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor
Francesco Piscitelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor
Fabricio A. Pamplona et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CB2: Therapeutic target-in-waiting
Brady K. Atwood et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Functional Selectivity and Biased Receptor Signaling
Terry Kenakin
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum
Xiaowei Wang et al.
MOLECULAR PHARMACOLOGY (2011)
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
Tricia H. Smith et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
N. L. Cluny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
CB1 Cannabinoid Receptors and their Associated Proteins
Allyn C. Howlett et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The role of conformational ensembles of seven transmembrane receptors in functional selectivity
Nagarajan Vaidehi et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Signal transduction of the CB1 cannabinoid receptor
Gabor Turu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Terry Kenakin et al.
PHARMACOLOGICAL REVIEWS (2010)
Functional Selectivity in Cannabinoid Signaling
E. Varga et al.
Current Molecular Pharmacology (2010)
Positive allosteric modulation of the human cannabinoid (CB1) receptor by RTI-371, a selective inhibitor of the dopamine transporter
Hernan A. Navarro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
David R. Janero et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Novel endogenous peptide agonists of cannabinoid receptors
Ivone Gomes et al.
FASEB JOURNAL (2009)
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
George Kunos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabinoid receptors: Where they are and what they do
K. Mackie
JOURNAL OF NEUROENDOCRINOLOGY (2008)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Tuning the endocannabinoid system:: allosteric modulators of the CB1 receptor
R. A. Ross
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Endocannabinoids and β-amyloid-induced neurotoxicity in vivo:: effect of pharmacological elevation of endocannabinoid levels
M. van der Stelt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins
JE Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Cannabinoids and ceramide:: Two lipids acting hand-by-hand
G Velasco et al.
LIFE SCIENCES (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Inverse agonism and neutral antagonism at cannabinoid CBI receptors
RG Pertwee
LIFE SCIENCES (2005)
The endocannabinoid system: Physiology and pharmacology
FR de Fonseca et al.
ALCOHOL AND ALCOHOLISM (2005)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Cannabinoid physiology and pharmacology: 30 years of progress
AC Howlett et al.
NEUROPHARMACOLOGY (2004)
Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery
A Christopoulos
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
